Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1bPhil McEwan, Hiromitsu Kumada, Kristine Broglio et al.|Value in Health Regional Issues|2014Cited by 16